Expensive hepatitis C drug Sovaldi to be made cheaper in developing countries Expensive hepatitis C drug Sovaldi, which has been developed by Gilead Sciences, will be cheaper in developing countries. Seven Indian companies will manufacture the drug. by Sumit Passary